IFN-τ mediated miR-26a targeting PTEN to activate PI3K/AKT signalling to alleviate the inflammatory damage of bEECs

Junfeng Liu, Qin Liang, Tianyang Wang, Bei Ma, Xin Wang, Ping Li, Aftab Shaukat, Xuefeng Guo, Ganzhen DengScientific 2022 · DOI

TL;DR

This study reveals a novel mechanism by which the ruminant-specific interferon, IFN-τ, combats endometrial inflammation. IFN-τ upregulates miR-26a, which then targets PTEN, activating the PI3K/AKT pathway and suppressing the pro-inflammatory NF-κB signaling, ultimately alleviating inflammatory damage in bovine endometrial epithelial cells (bEECs).

What Problem Does This Paper Address?

Endometritis, a common cause of infertility in dairy cows, stems from inflammatory damage to the uterine lining. While Type I interferons like IFN-τ are known to have immunomodulatory roles, the precise molecular mechanisms by which IFN-τ mitigates LPS-induced inflammatory injury in bovine endometrial epithelial cells (bEECs) remain unclear. Specifically, the role of microRNAs (miRNAs) in this process, particularly the conserved miR-26a, was not well understood. This paper aims to elucidate how IFN-τ, through miR-26a, impacts the inflammatory cascade in bEECs.

Methods

The researchers employed a multi-pronged approach:

  • In vitro inflammatory model: Bovine endometrial epithelial cells (bEECs) were cultured and treated with lipopolysaccharide (LPS) to mimic inflammatory injury.
  • Molecular analysis: RT-qPCR was used to quantify mRNA and miRNA expression levels of inflammatory cytokines (IL-1β, IL-6, TNF-α) and miR-26a. ELISA was employed to measure the secretion of these inflammatory factors.
  • miRNA function validation: Dual-luciferase assays were used to confirm direct targeting of PTEN by miR-26a. Target gene silencing assays (siRNA) were used to investigate the role of PTEN.
  • Protein analysis: Immunofluorescence and Western blotting were utilized to detect and quantify the expression and phosphorylation levels of key proteins involved in signaling pathways (PTEN, PI3K, AKT, NF-κB p65, TLR4).
  • In vivo validation: A mouse model of endometrial inflammatory injury was established to confirm the findings in a more complex biological system.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • IFN-τ as an anti-inflammatory agent: The study strongly supports IFN-τ's role as an anti-inflammatory agent in the endometrium, not just through general immune modulation but via a specific molecular pathway.
  • miR-26a as a key mediator: miR-26a emerges as a critical player, being downregulated during inflammation and upregulated by IFN-τ, suggesting it's a central hub in IFN-τ's protective mechanism.
  • PTEN as the direct target: The identification of PTEN as a direct target of miR-26a is a significant finding. This interaction is crucial for downstream signaling events.
  • PI3K/AKT activation as a consequence: The activation of the PI3K/AKT pathway, triggered by PTEN inhibition, is a key insight. This pathway is often associated with cell survival and anti-inflammatory responses.
  • NF-κB inhibition as the ultimate outcome: The ultimate effect of this cascade is the inhibition of NF-κB signaling, a master regulator of inflammatory responses, thereby reducing the inflammatory damage.
  • Translational regulation by miRNAs: The study highlights how miRNAs like miR-26a exert their effects primarily through translational repression of target genes (PTEN), rather than mRNA degradation.

Key Results

  • LPS stimulation significantly downregulated miR-26a expression in bEECs and mouse endometrial tissue.
  • IFN-τ treatment reversed this downregulation, significantly increasing miR-26a levels.
  • Overexpression of miR-26a significantly inhibited the secretion of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α).
  • miR-26a directly targets the 3'-UTR of PTEN mRNA, inhibiting its translation.
  • Inhibition of PTEN by miR-26a led to the activation of the PI3K/AKT pathway.
  • This activation of PI3K/AKT subsequently inhibited NF-κB signaling.
  • In vivo experiments in mice confirmed that IFN-τ treatment reduced endometrial inflammatory injury, suppressed inflammatory cytokine expression, and decreased p65 phosphorylation.

Limitations and Future Work

  • In vitro vs. in vivo complexity: While the study uses both in vitro and in vivo models, the full complexity of the endometrial environment and its interactions with other immune cells are not fully captured.
  • Broader miRNA roles: The study focuses on miR-26a. It's possible other miRNAs also contribute to IFN-τ's anti-inflammatory effects.
  • Clinical translation: The findings are in bovine models. Further research would be needed to explore the potential therapeutic applications in human endometritis or other inflammatory conditions.
  • PTEN's multifaceted roles: While PTEN is a known tumor suppressor and regulator of cell growth, its specific roles in endometrial inflammation beyond this study's scope could be further investigated.

The authors suggest that IFN-τ, by targeting PTEN via miR-26a to activate PI3K/AKT and inhibit NF-κB, offers a promising therapeutic avenue for managing inflammatory damage in the endometrium.

Summary updated

Abstract

Endometritis is the failure of embryo implantation and an important cause of infertility in dairy cows. IFN-τ is a type I interferon unique to ruminants. In regulating the process of inflammatory response, IFN-τ can be expressed through MicroRNAs (miRNAs) to regulate the process of inflammation. However, IFN-τ regulates lipopolysaccharide (LPS)-induced inflammatory injury of bEECs through the highly conserved miR-26a in mammals, and the mechanism remains unclear. Bovine endometrial epithelial cells (bEECs)were isolated and cultured to establish an inflammatory injury model. RT-qPCR and ELISA were used to detect the secretion of inflammatory factors. Dual-luciferase assays and target gene silencing assays determine the regulatory role of miRNAs. The target protein was detected by immunofluorescence and western blotting. This study showed that the expression of miR-26a was significantly down-regulated in mouse endometrium inflammatory injury tissue and LPS stimulated bEECs; and IFN-τ reversed the expression of miR-26a. The study also showed that the overexpression of miR-26a significantly inhibited the secretion of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α. In addition, studies have shown that miR-26a inhibits its translation by targeting PTEN 3'-UTR, which in turn activates the Phosphatidylinositide 3-kinases/protein kinase B (PI3K/AKT) pathway, so that nuclear factor kappa-B (NF-κB) signaling is inhibited. In summary, the results of this study further confirm that IFN-τ as an anti-inflammatory agent can up-regulate the expression of miR-26a and target the PTEN gene to inhibit the inflammatory damage of bEECs.
BibTeX
@inproceedings{liu2022ifn,
  author = {Junfeng Liu and Qin Liang and Tianyang Wang and Bei Ma and Xin Wang and Ping Li and Aftab Shaukat and Xuefeng Guo and Ganzhen Deng},
  title = {{IFN-τ mediated miR-26a targeting PTEN to activate PI3K/AKT signalling to alleviate the inflammatory damage of bEECs}},
  booktitle = {Scientific},
  year = {2022},
  doi = {10.1038/s41598-022-12681-9},
}
Figure